Coya Therapeutics (COYA) News Today $6.01 -0.14 (-2.28%) Closing price 04:00 PM EasternExtended Trading$6.04 +0.03 (+0.50%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock COYA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Coya Therapeutics' (COYA) "Buy" Rating Reaffirmed at Chardan CapitalAugust 16 at 3:25 AM | americanbankingnews.comCoya Therapeutics (NASDAQ:COYA) Earns "Buy" Rating from D. Boral CapitalAugust 15 at 1:03 PM | marketbeat.comChardan Capital Reaffirms Buy Rating for Coya Therapeutics (NASDAQ:COYA)August 15 at 11:14 AM | marketbeat.comCoya Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues LagAugust 14, 2025 | finance.yahoo.comCoya Therapeutics (NASDAQ:COYA) Receives Buy Rating from D. Boral CapitalAugust 14, 2025 | americanbankingnews.comCoya Therapeutics (NASDAQ:COYA) Issues Earnings ResultsAugust 13, 2025 | marketbeat.comCoya Therapeutics Reports Increased Losses Amid Development FocusAugust 12, 2025 | tipranks.comCoya Therapeutics, Inc.: Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate UpdateAugust 12, 2025 | finanznachrichten.deCoya Therapeutics files $75M mixed securities shelfAugust 12, 2025 | msn.comCoya Therapeutics Highlights Q2 2025 Financial ResultsAugust 12, 2025 | tipranks.comCoya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate UpdateAugust 12, 2025 | prnewswire.comCoya Therapeutics (COYA) to Release Earnings on MondayAugust 10, 2025 | americanbankingnews.comCM Management LLC Raises Stock Position in Coya Therapeutics, Inc. (NASDAQ:COYA)August 7, 2025 | marketbeat.comCoya Therapeutics (COYA) Expected to Announce Quarterly Earnings on MondayAugust 5, 2025 | marketbeat.comDauntless Investment Group LLC Acquires Shares of 167,378 Coya Therapeutics, Inc. (NASDAQ:COYA)July 29, 2025 | marketbeat.comCoya Therapeutics' (COYA) "Buy" Rating Reiterated at D. Boral CapitalJuly 25, 2025 | marketbeat.comCoya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025July 22, 2025 | finance.yahoo.comCoya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025July 22, 2025 | businesswire.comLake Street Initiates Coverage of Coya Therapeutics (COYA) with Buy RecommendationJuly 10, 2025 | msn.comLake Street Capital Initiates Coverage on Coya Therapeutics (NASDAQ:COYA)July 9, 2025 | marketbeat.comCoya Therapeutics resubmits IND application for ALS Phase 2 study to FDA - Investing.comJuly 2, 2025 | investing.comPositive Outlook for Coya Therapeutics, Inc. Driven by IND Resubmission and Promising Trial ResultsJuly 1, 2025 | tipranks.comCoya Therapeutics (NASDAQ:COYA) Given Buy Rating at Chardan CapitalJuly 1, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Trading Down 1.7% - Should You Sell?July 1, 2025 | marketbeat.comAfter myriad failures, a new wave of ALS drugs approachesJune 25, 2025 | finance.yahoo.comCoya Therapeutics Inc News - MorningstarJune 24, 2025 | morningstar.comMCoya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025June 18, 2025 | businesswire.comCoya Therapeutics: How Fair Value analysis predicted 40% downside in biotech stockJune 12, 2025 | uk.investing.comCoya Therapeutics (NASDAQ:COYA) Earns "Buy" Rating from HC WainwrightJune 9, 2025 | marketbeat.comCoya Therapeutics secures patent for IL-2 liquid formulationJune 4, 2025 | uk.investing.comEquities Analysts Offer Predictions for COYA Q3 EarningsMay 23, 2025 | marketbeat.comQ1 Earnings Estimate for COYA Issued By HC WainwrightMay 22, 2025 | marketbeat.comChardan Capital Has Negative Outlook of COYA FY2025 EarningsMay 21, 2025 | marketbeat.comCoya Therapeutics First Quarter 2025 Earnings: Misses ExpectationsMay 20, 2025 | finance.yahoo.comCoya Therapeutics: Promising Developments and Strategic Partnerships Drive Buy RatingMay 19, 2025 | tipranks.comCoya Therapeutics to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor ConferenceMay 16, 2025 | businesswire.comDME Capital Management LP Buys 372,414 Shares of Coya Therapeutics, Inc. (NASDAQ:COYA)May 10, 2025 | marketbeat.comCoya Therapeutics to Participate in Two Upcoming Conferences in May 2025May 8, 2025 | finance.yahoo.comSibylla Biotech Appoints Former Bayer CEO, Dieter Weinand, as Chairman of the Board of DirectorsMay 8, 2025 | globenewswire.comCoya Therapeutics (COYA) to Release Earnings on ThursdayMay 3, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Receives "Buy" Rating from Chardan CapitalApril 30, 2025 | marketbeat.comCoya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with ...April 26, 2025 | businesswire.comCoya Therapeutics: Treg Proof-Of-Concept Continues With Interim FTD Data ReleaseApril 25, 2025 | seekingalpha.comCoya Therapeutics reports interim results from IL-2, CTLA4-Ig combination studyApril 25, 2025 | markets.businessinsider.comPromising Outlook for Coya Therapeutics: Buy Rating Justified by Innovative Treatments and Pipeline PotentialApril 25, 2025 | tipranks.comCoya Therapeutics Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection ...April 23, 2025 | seekingalpha.comCoya Therapeutics (NASDAQ:COYA) Trading 8.6% Higher - What's Next?April 23, 2025 | marketbeat.comAtea Pharmaceuticals appoints Howard Berman to board of directorsApril 17, 2025 | markets.businessinsider.comIs Coya Therapeutics (COYA) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?April 11, 2025 | insidermonkey.comIs Coya Therapeutics (COYA) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?April 11, 2025 | msn.com Get Coya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COYA and its competitors with MarketBeat's FREE daily newsletter. Email Address COYA Media Mentions By Week COYA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COYA News Sentiment▼0.120.66▲Average Medical News Sentiment COYA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COYA Articles This Week▼162▲COYA Articles Average Week Get Coya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Replimune Group News Today REGENXBIO News Today Tectonic Therapeutic News Today Prothena News Today COMPASS Pathways News Today Arcturus Therapeutics News Today Y-mAbs Therapeutics News Today Vigil Neuroscience News Today Aquestive Therapeutics News Today Astria Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COYA) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access